Drugs / ASP2016
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06483802 | Nov 2024 → Oct 2025 | Friedreich ataxia, cardiomyopathy | Astellas Gene Therapies | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASP2016 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06483802 ↗ |
| Route | Intravenous | “ASP2016 is given as a slow injection into a vein.” NCT06483802 ↗ |